カテゴリー： QYResearch, 世界

世界の自己免疫＆炎症性免疫調節薬市場 2019年

【英語タイトル】Global Autoimmune and Inflammatory Immunomodulators Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X03838）・商品コード：DATA909X03838
・発行会社（調査会社）：QYResearch
・発行日：2019年11月15日（※2024年版があります。お問い合わせください）
・ページ数：111
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、自己免疫＆炎症性免疫調節薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、生物製剤、小分子に、用途別には、関節リウマチ、IBDにセグメント区分し、自己免疫＆炎症性免疫調節薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・自己免疫＆炎症性免疫調節薬の世界市場概要
・自己免疫＆炎症性免疫調節薬の製造コスト構成分析
・自己免疫＆炎症性免疫調節薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・自己免疫＆炎症性免疫調節薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・自己免疫＆炎症性免疫調節薬のセグメント分析（種類別）
（生物製剤、小分子）
・自己免疫＆炎症性免疫調節薬のセグメント分析（用途別）
（関節リウマチ、IBD）
・自己免疫＆炎症性免疫調節薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（AbbVie、Johnson & Johnson、Amgen、F. Hoffmann-La Roche、Pfizer、AstraZeneca、Avaxia Biologics、Biogen Idec、Bristol-Myers Squibb、Boehringer Ingelheim、Eli Lilly、Enlivex Therapeutics、Gilead Sciences、）
・自己免疫＆炎症性免疫調節薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Autoimmune and Inflammatory Immunomodulators market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Autoimmune and Inflammatory Immunomodulators volume and value at global level, regional level and company level. From a global perspective, this report represents overall Autoimmune and Inflammatory Immunomodulators market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Autoimmune and Inflammatory Immunomodulators in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Autoimmune and Inflammatory Immunomodulators manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
AbbVie
Johnson & Johnson
Amgen
F. Hoffmann-La Roche
Pfizer
AstraZeneca
Avaxia Biologics
Biogen Idec
Bristol-Myers Squibb
Boehringer Ingelheim
Eli Lilly
Enlivex Therapeutics
Gilead Sciences

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Biologics
Small molecules

Segment by Application
Rheumatoid arthritis
IBD

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Autoimmune and Inflammatory Immunomodulators
1.1 Definition of Autoimmune and Inflammatory Immunomodulators
1.2 Autoimmune and Inflammatory Immunomodulators Segment by Type
1.2.1 Global Autoimmune and Inflammatory Immunomodulators Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Biologics
1.2.3 Small molecules
1.3 Autoimmune and Inflammatory Immunomodulators Segment by Applications
1.3.1 Global Autoimmune and Inflammatory Immunomodulators Consumption Comparison by Applications (2014-2025)
1.3.2 Rheumatoid arthritis
1.3.3 IBD
1.4 Global Autoimmune and Inflammatory Immunomodulators Overall Market
1.4.1 Global Autoimmune and Inflammatory Immunomodulators Revenue (2014-2025)
1.4.2 Global Autoimmune and Inflammatory Immunomodulators Production (2014-2025)
1.4.3 North America Autoimmune and Inflammatory Immunomodulators Status and Prospect (2014-2025)
1.4.4 Europe Autoimmune and Inflammatory Immunomodulators Status and Prospect (2014-2025)
1.4.5 China Autoimmune and Inflammatory Immunomodulators Status and Prospect (2014-2025)
1.4.6 Japan Autoimmune and Inflammatory Immunomodulators Status and Prospect (2014-2025)
1.4.7 Southeast Asia Autoimmune and Inflammatory Immunomodulators Status and Prospect (2014-2025)
1.4.8 India Autoimmune and Inflammatory Immunomodulators Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Autoimmune and Inflammatory Immunomodulators
2.3 Manufacturing Process Analysis of Autoimmune and Inflammatory Immunomodulators
2.4 Industry Chain Structure of Autoimmune and Inflammatory Immunomodulators

3 Development and Manufacturing Plants Analysis of Autoimmune and Inflammatory Immunomodulators
3.1 Capacity and Commercial Production Date
3.2 Global Autoimmune and Inflammatory Immunomodulators Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Autoimmune and Inflammatory Immunomodulators
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Autoimmune and Inflammatory Immunomodulators Production and Capacity Analysis
4.2 Autoimmune and Inflammatory Immunomodulators Revenue Analysis
4.3 Autoimmune and Inflammatory Immunomodulators Price Analysis
4.4 Market Concentration Degree

5 Autoimmune and Inflammatory Immunomodulators Regional Market Analysis
5.1 Autoimmune and Inflammatory Immunomodulators Production by Regions
5.1.1 Global Autoimmune and Inflammatory Immunomodulators Production by Regions
5.1.2 Global Autoimmune and Inflammatory Immunomodulators Revenue by Regions
5.2 Autoimmune and Inflammatory Immunomodulators Consumption by Regions
5.3 North America Autoimmune and Inflammatory Immunomodulators Market Analysis
5.3.1 North America Autoimmune and Inflammatory Immunomodulators Production
5.3.2 North America Autoimmune and Inflammatory Immunomodulators Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Autoimmune and Inflammatory Immunomodulators Import and Export
5.4 Europe Autoimmune and Inflammatory Immunomodulators Market Analysis
5.4.1 Europe Autoimmune and Inflammatory Immunomodulators Production
5.4.2 Europe Autoimmune and Inflammatory Immunomodulators Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Autoimmune and Inflammatory Immunomodulators Import and Export
5.5 China Autoimmune and Inflammatory Immunomodulators Market Analysis
5.5.1 China Autoimmune and Inflammatory Immunomodulators Production
5.5.2 China Autoimmune and Inflammatory Immunomodulators Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Autoimmune and Inflammatory Immunomodulators Import and Export
5.6 Japan Autoimmune and Inflammatory Immunomodulators Market Analysis
5.6.1 Japan Autoimmune and Inflammatory Immunomodulators Production
5.6.2 Japan Autoimmune and Inflammatory Immunomodulators Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Autoimmune and Inflammatory Immunomodulators Import and Export
5.7 Southeast Asia Autoimmune and Inflammatory Immunomodulators Market Analysis
5.7.1 Southeast Asia Autoimmune and Inflammatory Immunomodulators Production
5.7.2 Southeast Asia Autoimmune and Inflammatory Immunomodulators Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Autoimmune and Inflammatory Immunomodulators Import and Export
5.8 India Autoimmune and Inflammatory Immunomodulators Market Analysis
5.8.1 India Autoimmune and Inflammatory Immunomodulators Production
5.8.2 India Autoimmune and Inflammatory Immunomodulators Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Autoimmune and Inflammatory Immunomodulators Import and Export

6 Autoimmune and Inflammatory Immunomodulators Segment Market Analysis (by Type)
6.1 Global Autoimmune and Inflammatory Immunomodulators Production by Type
6.2 Global Autoimmune and Inflammatory Immunomodulators Revenue by Type
6.3 Autoimmune and Inflammatory Immunomodulators Price by Type

7 Autoimmune and Inflammatory Immunomodulators Segment Market Analysis (by Application)
7.1 Global Autoimmune and Inflammatory Immunomodulators Consumption by Application
7.2 Global Autoimmune and Inflammatory Immunomodulators Consumption Market Share by Application (2014-2019)

8 Autoimmune and Inflammatory Immunomodulators Major Manufacturers Analysis
8.1 AbbVie
8.1.1 AbbVie Autoimmune and Inflammatory Immunomodulators Production Sites and Area Served
8.1.2 AbbVie Product Introduction, Application and Specification
8.1.3 AbbVie Autoimmune and Inflammatory Immunomodulators Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Johnson & Johnson
8.2.1 Johnson & Johnson Autoimmune and Inflammatory Immunomodulators Production Sites and Area Served
8.2.2 Johnson & Johnson Product Introduction, Application and Specification
8.2.3 Johnson & Johnson Autoimmune and Inflammatory Immunomodulators Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Amgen
8.3.1 Amgen Autoimmune and Inflammatory Immunomodulators Production Sites and Area Served
8.3.2 Amgen Product Introduction, Application and Specification
8.3.3 Amgen Autoimmune and Inflammatory Immunomodulators Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 F. Hoffmann-La Roche
8.4.1 F. Hoffmann-La Roche Autoimmune and Inflammatory Immunomodulators Production Sites and Area Served
8.4.2 F. Hoffmann-La Roche Product Introduction, Application and Specification
8.4.3 F. Hoffmann-La Roche Autoimmune and Inflammatory Immunomodulators Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Pfizer
8.5.1 Pfizer Autoimmune and Inflammatory Immunomodulators Production Sites and Area Served
8.5.2 Pfizer Product Introduction, Application and Specification
8.5.3 Pfizer Autoimmune and Inflammatory Immunomodulators Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 AstraZeneca
8.6.1 AstraZeneca Autoimmune and Inflammatory Immunomodulators Production Sites and Area Served
8.6.2 AstraZeneca Product Introduction, Application and Specification
8.6.3 AstraZeneca Autoimmune and Inflammatory Immunomodulators Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Avaxia Biologics
8.7.1 Avaxia Biologics Autoimmune and Inflammatory Immunomodulators Production Sites and Area Served
8.7.2 Avaxia Biologics Product Introduction, Application and Specification
8.7.3 Avaxia Biologics Autoimmune and Inflammatory Immunomodulators Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Biogen Idec
8.8.1 Biogen Idec Autoimmune and Inflammatory Immunomodulators Production Sites and Area Served
8.8.2 Biogen Idec Product Introduction, Application and Specification
8.8.3 Biogen Idec Autoimmune and Inflammatory Immunomodulators Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Bristol-Myers Squibb
8.9.1 Bristol-Myers Squibb Autoimmune and Inflammatory Immunomodulators Production Sites and Area Served
8.9.2 Bristol-Myers Squibb Product Introduction, Application and Specification
8.9.3 Bristol-Myers Squibb Autoimmune and Inflammatory Immunomodulators Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Boehringer Ingelheim
8.10.1 Boehringer Ingelheim Autoimmune and Inflammatory Immunomodulators Production Sites and Area Served
8.10.2 Boehringer Ingelheim Product Introduction, Application and Specification
8.10.3 Boehringer Ingelheim Autoimmune and Inflammatory Immunomodulators Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Eli Lilly
8.12 Enlivex Therapeutics
8.13 Gilead Sciences

9 Development Trend of Analysis of Autoimmune and Inflammatory Immunomodulators Market
9.1 Global Autoimmune and Inflammatory Immunomodulators Market Trend Analysis
9.1.1 Global Autoimmune and Inflammatory Immunomodulators Market Size (Volume and Value) Forecast 2019-2025
9.2 Autoimmune and Inflammatory Immunomodulators Regional Market Trend
9.2.1 North America Autoimmune and Inflammatory Immunomodulators Forecast 2019-2025
9.2.2 Europe Autoimmune and Inflammatory Immunomodulators Forecast 2019-2025
9.2.3 China Autoimmune and Inflammatory Immunomodulators Forecast 2019-2025
9.2.4 Japan Autoimmune and Inflammatory Immunomodulators Forecast 2019-2025
9.2.5 Southeast Asia Autoimmune and Inflammatory Immunomodulators Forecast 2019-2025
9.2.6 India Autoimmune and Inflammatory Immunomodulators Forecast 2019-2025
9.3 Autoimmune and Inflammatory Immunomodulators Market Trend (Product Type)
9.4 Autoimmune and Inflammatory Immunomodulators Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Autoimmune and Inflammatory Immunomodulators Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Autoimmune and Inflammatory Immunomodulators
Table Global Autoimmune and Inflammatory Immunomodulators Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Autoimmune and Inflammatory Immunomodulators Production Market Share by Types in 2018
Figure Biologics Product Picture
Figure Small molecules Product Picture
Table Global Autoimmune and Inflammatory Immunomodulators Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Autoimmune and Inflammatory Immunomodulators Consumption Market Share by Applications in 2018
Figure Rheumatoid arthritis
Figure IBD
Figure Global Autoimmune and Inflammatory Immunomodulators Revenue (Million USD) (2014-2025)
Figure Global Autoimmune and Inflammatory Immunomodulators Production (K Units) (2014-2025)
Figure North America Autoimmune and Inflammatory Immunomodulators Market Size (Million USD) (2014-2025)
Figure Europe Autoimmune and Inflammatory Immunomodulators Market Size (Million USD) (2014-2025)
Figure China Autoimmune and Inflammatory Immunomodulators Market Size (Million USD) (2014-2025)
Figure Japan Autoimmune and Inflammatory Immunomodulators Market Size (Million USD) (2014-2025)
Figure Southeast Asia Autoimmune and Inflammatory Immunomodulators Market Size (Million USD) (2014-2025)
Figure India Autoimmune and Inflammatory Immunomodulators Market Size (Million USD) (2014-2025)
Table Autoimmune and Inflammatory Immunomodulators Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Autoimmune and Inflammatory Immunomodulators in 2018
Figure Manufacturing Process Analysis of Autoimmune and Inflammatory Immunomodulators
Figure Industry Chain Structure of Autoimmune and Inflammatory Immunomodulators
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Autoimmune and Inflammatory Immunomodulators Manufacturing Plants Distribution
Table Autoimmune and Inflammatory Immunomodulators Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Autoimmune and Inflammatory Immunomodulators Capacity (K Units) of Major Manufacturers (2014-2019)
Table Autoimmune and Inflammatory Immunomodulators Production (K Units) of Major Manufacturers (2014-2019)
Table Autoimmune and Inflammatory Immunomodulators Production Market Share of Major Manufacturers (2014-2019)
Figure Autoimmune and Inflammatory Immunomodulators Production Share by Manufacturers in 2018
Table Autoimmune and Inflammatory Immunomodulators Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Autoimmune and Inflammatory Immunomodulators Revenue Market Share of Major Manufacturers (2014-2019)
Figure Autoimmune and Inflammatory Immunomodulators Revenue Share by Manufacturers in 2018
Table Autoimmune and Inflammatory Immunomodulators Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Autoimmune and Inflammatory Immunomodulators Production by Regions 2014-2019 (K Units)
Table Global Autoimmune and Inflammatory Immunomodulators Production Market Share by Regions 2014-2019
Figure Global Autoimmune and Inflammatory Immunomodulators Production Market Share by Regions in 2018
Table Global Autoimmune and Inflammatory Immunomodulators Revenue by Regions 2014-2019 (Million USD)
Table Global Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Regions 2014-2019
Figure Global Autoimmune and Inflammatory Immunomodulators Revenue Market Share by Regions in 2018
Table Global Autoimmune and Inflammatory Immunomodulators Consumption by Regions 2014-2019 (K Units)
Table Global Autoimmune and Inflammatory Immunomodulators Consumption Market Share by Regions 2014-2019
Figure North America Autoimmune and Inflammatory Immunomodulators Production Growth Rate 2014-2019 (K Units)
Figure North America Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate 2014-2019 (Million USD)
Table North America Autoimmune and Inflammatory Immunomodulators Production, Consumption Import and Export (K Units)
Figure Europe Autoimmune and Inflammatory Immunomodulators Production Growth Rate 2014-2019 (K Units)
Figure Europe Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Autoimmune and Inflammatory Immunomodulators Production, Consumption Import and Export (K Units)
Figure China Autoimmune and Inflammatory Immunomodulators Production Growth Rate 2014-2019 (K Units)
Figure China Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate 2014-2019 (Million USD)
Table China Autoimmune and Inflammatory Immunomodulators Production, Consumption Import and Export (K Units)
Figure Japan Autoimmune and Inflammatory Immunomodulators Production Growth Rate 2014-2019 (K Units)
Figure Japan Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Autoimmune and Inflammatory Immunomodulators Production, Consumption Import and Export (K Units)
Figure Southeast Asia Autoimmune and Inflammatory Immunomodulators Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Autoimmune and Inflammatory Immunomodulators Production, Consumption Import and Export (K Units)
Figure India Autoimmune and Inflammatory Immunomodulators Production Growth Rate 2014-2019 (K Units)
Figure India Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate 2014-2019 (Million USD)
Table India Autoimmune and Inflammatory Immunomodulators Production, Consumption Import and Export (K Units)
Figure Global Consumption Autoimmune and Inflammatory Immunomodulators Market Share by Application (2014-2019)
Figure Global Value (Consumption) Autoimmune and Inflammatory Immunomodulators Market Share by Application (2014-2019)
Table AbbVie Autoimmune and Inflammatory Immunomodulators Production Sites and Area Served
Table AbbVie Autoimmune and Inflammatory Immunomodulators Product Introduction, Application and Specification
Table AbbVie Autoimmune and Inflammatory Immunomodulators Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table AbbVie Autoimmune and Inflammatory Immunomodulators Production Growth Rate (2014-2019)
Table AbbVie Autoimmune and Inflammatory Immunomodulators Production Market Share (2014-2019)
Figure AbbVie Autoimmune and Inflammatory Immunomodulators Revenue Market Share (2014-2019)
Table AbbVie Autoimmune and Inflammatory Immunomodulators Main Business and Markets Served
Table Johnson & Johnson Autoimmune and Inflammatory Immunomodulators Production Sites and Area Served
Table Johnson & Johnson Autoimmune and Inflammatory Immunomodulators Product Introduction, Application and Specification
Table Johnson & Johnson Autoimmune and Inflammatory Immunomodulators Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson & Johnson Autoimmune and Inflammatory Immunomodulators Production Growth Rate (2014-2019)
Table Johnson & Johnson Autoimmune and Inflammatory Immunomodulators Production Market Share (2014-2019)
Figure Johnson & Johnson Autoimmune and Inflammatory Immunomodulators Revenue Market Share (2014-2019)
Table Johnson & Johnson Autoimmune and Inflammatory Immunomodulators Main Business and Markets Served
Table Amgen Autoimmune and Inflammatory Immunomodulators Production Sites and Area Served
Table Amgen Autoimmune and Inflammatory Immunomodulators Product Introduction, Application and Specification
Table Amgen Autoimmune and Inflammatory Immunomodulators Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Amgen Autoimmune and Inflammatory Immunomodulators Production Growth Rate (2014-2019)
Table Amgen Autoimmune and Inflammatory Immunomodulators Production Market Share (2014-2019)
Figure Amgen Autoimmune and Inflammatory Immunomodulators Revenue Market Share (2014-2019)
Table Amgen Autoimmune and Inflammatory Immunomodulators Main Business and Markets Served
Table F. Hoffmann-La Roche Autoimmune and Inflammatory Immunomodulators Production Sites and Area Served
Table F. Hoffmann-La Roche Autoimmune and Inflammatory Immunomodulators Product Introduction, Application and Specification
Table F. Hoffmann-La Roche Autoimmune and Inflammatory Immunomodulators Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Autoimmune and Inflammatory Immunomodulators Production Growth Rate (2014-2019)
Table F. Hoffmann-La Roche Autoimmune and Inflammatory Immunomodulators Production Market Share (2014-2019)
Figure F. Hoffmann-La Roche Autoimmune and Inflammatory Immunomodulators Revenue Market Share (2014-2019)
Table F. Hoffmann-La Roche Autoimmune and Inflammatory Immunomodulators Main Business and Markets Served
Table Pfizer Autoimmune and Inflammatory Immunomodulators Production Sites and Area Served
Table Pfizer Autoimmune and Inflammatory Immunomodulators Product Introduction, Application and Specification
Table Pfizer Autoimmune and Inflammatory Immunomodulators Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Autoimmune and Inflammatory Immunomodulators Production Growth Rate (2014-2019)
Table Pfizer Autoimmune and Inflammatory Immunomodulators Production Market Share (2014-2019)
Figure Pfizer Autoimmune and Inflammatory Immunomodulators Revenue Market Share (2014-2019)
Table Pfizer Autoimmune and Inflammatory Immunomodulators Main Business and Markets Served
Table AstraZeneca Autoimmune and Inflammatory Immunomodulators Production Sites and Area Served
Table AstraZeneca Autoimmune and Inflammatory Immunomodulators Product Introduction, Application and Specification
Table AstraZeneca Autoimmune and Inflammatory Immunomodulators Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Autoimmune and Inflammatory Immunomodulators Production Growth Rate (2014-2019)
Table AstraZeneca Autoimmune and Inflammatory Immunomodulators Production Market Share (2014-2019)
Figure AstraZeneca Autoimmune and Inflammatory Immunomodulators Revenue Market Share (2014-2019)
Table AstraZeneca Autoimmune and Inflammatory Immunomodulators Main Business and Markets Served
Table Avaxia Biologics Autoimmune and Inflammatory Immunomodulators Production Sites and Area Served
Table Avaxia Biologics Autoimmune and Inflammatory Immunomodulators Product Introduction, Application and Specification
Table Avaxia Biologics Autoimmune and Inflammatory Immunomodulators Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Avaxia Biologics Autoimmune and Inflammatory Immunomodulators Production Growth Rate (2014-2019)
Table Avaxia Biologics Autoimmune and Inflammatory Immunomodulators Production Market Share (2014-2019)
Figure Avaxia Biologics Autoimmune and Inflammatory Immunomodulators Revenue Market Share (2014-2019)
Table Avaxia Biologics Autoimmune and Inflammatory Immunomodulators Main Business and Markets Served
Table Biogen Idec Autoimmune and Inflammatory Immunomodulators Production Sites and Area Served
Table Biogen Idec Autoimmune and Inflammatory Immunomodulators Product Introduction, Application and Specification
Table Biogen Idec Autoimmune and Inflammatory Immunomodulators Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Biogen Idec Autoimmune and Inflammatory Immunomodulators Production Growth Rate (2014-2019)
Table Biogen Idec Autoimmune and Inflammatory Immunomodulators Production Market Share (2014-2019)
Figure Biogen Idec Autoimmune and Inflammatory Immunomodulators Revenue Market Share (2014-2019)
Table Biogen Idec Autoimmune and Inflammatory Immunomodulators Main Business and Markets Served
Table Bristol-Myers Squibb Autoimmune and Inflammatory Immunomodulators Production Sites and Area Served
Table Bristol-Myers Squibb Autoimmune and Inflammatory Immunomodulators Product Introduction, Application and Specification
Table Bristol-Myers Squibb Autoimmune and Inflammatory Immunomodulators Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Autoimmune and Inflammatory Immunomodulators Production Growth Rate (2014-2019)
Table Bristol-Myers Squibb Autoimmune and Inflammatory Immunomodulators Production Market Share (2014-2019)
Figure Bristol-Myers Squibb Autoimmune and Inflammatory Immunomodulators Revenue Market Share (2014-2019)
Table Bristol-Myers Squibb Autoimmune and Inflammatory Immunomodulators Main Business and Markets Served
Table Boehringer Ingelheim Autoimmune and Inflammatory Immunomodulators Production Sites and Area Served
Table Boehringer Ingelheim Autoimmune and Inflammatory Immunomodulators Product Introduction, Application and Specification
Table Boehringer Ingelheim Autoimmune and Inflammatory Immunomodulators Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Autoimmune and Inflammatory Immunomodulators Production Growth Rate (2014-2019)
Table Boehringer Ingelheim Autoimmune and Inflammatory Immunomodulators Production Market Share (2014-2019)
Figure Boehringer Ingelheim Autoimmune and Inflammatory Immunomodulators Revenue Market Share (2014-2019)
Table Boehringer Ingelheim Autoimmune and Inflammatory Immunomodulators Main Business and Markets Served
Table Eli Lilly Autoimmune and Inflammatory Immunomodulators Production Sites and Area Served
Table Enlivex Therapeutics Autoimmune and Inflammatory Immunomodulators Production Sites and Area Served
Table Gilead Sciences Autoimmune and Inflammatory Immunomodulators Production Sites and Area Served
Figure Global Autoimmune and Inflammatory Immunomodulators Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Autoimmune and Inflammatory Immunomodulators Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Autoimmune and Inflammatory Immunomodulators Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Autoimmune and Inflammatory Immunomodulators Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Autoimmune and Inflammatory Immunomodulators Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Autoimmune and Inflammatory Immunomodulators Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Autoimmune and Inflammatory Immunomodulators Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Autoimmune and Inflammatory Immunomodulators Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Autoimmune and Inflammatory Immunomodulators Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Autoimmune and Inflammatory Immunomodulators Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Autoimmune and Inflammatory Immunomodulators by Type (2019-2025)
Table Global Consumption (K Units) of Autoimmune and Inflammatory Immunomodulators by Application (2019-2025)
Table Autoimmune and Inflammatory Immunomodulators Distributors List
Table Autoimmune and Inflammatory Immunomodulators Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

AbbVie、Johnson & Johnson、Amgen、F. Hoffmann-La Roche、Pfizer、AstraZeneca、Avaxia Biologics、Biogen Idec、Bristol-Myers Squibb、Boehringer Ingelheim、Eli Lilly、Enlivex Therapeutics、Gilead Sciences、

★調査レポート[世界の自己免疫＆炎症性免疫調節薬市場 2019年] (コード：DATA909X03838)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の自己免疫＆炎症性免疫調節薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の炎症性腸疾患治療市場 2019年
    DATA909X09776 / QYResearch / 2019年11月20日 / ※本調査レポートは、炎症性腸疾患治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アミノサリチル酸塩、TNF阻害剤、コルチコステロイド、免疫調節剤に、用途別には、小売薬局、病院薬局、オンライン薬局にセグメント区分し、炎症性腸疾患治療の世界市場を分析しました。 ・エグゼクティブ・サマリー ・炎症性腸疾患治療の世界市場概要 ・炎症性腸疾患治療の製造コスト構成分析 ・炎症性腸疾患治療の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・炎症性腸疾患治療の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・炎症性腸疾患治療のセグメント分析（種類別） （アミノサリチル酸塩、TNF阻害剤、コルチコステロイド、免疫調節剤）...The global Inflammatory Bowel Disease Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Inflammatory Bowel Disease Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Inflammatory Bowel Disease Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Inflammatory Bowel Disease Treatment in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の限局性自己免疫疾患診断市場 2019年
    DATA909X10691 / QYResearch / 2019年11月20日 / ※本調査レポートは、限局性自己免疫疾患診断の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、多発性硬化症、1型糖尿病、橋本甲状腺炎、特発性血小板減少性紫斑病、その他に、用途別には、病院、診療所、研究所、実験室にセグメント区分し、限局性自己免疫疾患診断の世界市場を分析しました。 ・エグゼクティブ・サマリー ・限局性自己免疫疾患診断の世界市場概要 ・限局性自己免疫疾患診断の製造コスト構成分析 ・限局性自己免疫疾患診断の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・限局性自己免疫疾患診断の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・限局性自己免疫疾患診断のセグメント分析（種類別） （多発性硬化症、1型糖尿病、橋本甲状腺炎、特発性血小板減少性紫斑病、その他）...The global Localized Autoimmune Disease Diagnostics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Localized Autoimmune Disease Diagnostics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Localized Autoimmune Disease Diagnostics market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Localized Autoimmune Disease Diagnostics in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の抗炎症性抗生物質点眼剤市場 2019年
    DATA909X03655 / QYResearch / 2019年11月15日 / ※本調査レポートは、抗炎症性抗生物質点眼剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、クロラムフェニコール、リファンピシン、ノルフロキサシン、モイスン、エリスロマイシンに、用途別には、大人、子供にセグメント区分し、抗炎症性抗生物質点眼剤の世界市場を分析しました。 ・エグゼクティブ・サマリー ・抗炎症性抗生物質点眼剤の世界市場概要 ・抗炎症性抗生物質点眼剤の製造コスト構成分析 ・抗炎症性抗生物質点眼剤の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・抗炎症性抗生物質点眼剤の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・抗炎症性抗生物質点眼剤のセグメント分析（種類別） （クロラムフェニコール、リファンピシン、ノルフロキサシン、モイスン、エリスロマイシン）...The global Anti-inflammatory antibiotics EyeDrops market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Anti-inflammatory antibiotics EyeDrops volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anti-inflammatory antibiotics EyeDrops market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Anti-inflammatory antibiotics EyeDrops in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 自己免疫性肝炎治療の世界市場：規模・現状・予測2019-2025
    DATA909X18186 / QYResearch / 2019年11月25日 / ※当調査レポートでは、自己免疫性肝炎治療の世界市場について調査・分析し、自己免疫性肝炎治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（テーブル製品、インジェクト製品、その他）、用途別（病院、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の自己免疫性肝炎治療市場動向 ・主要企業別マーケットシェア ・自己免疫性肝炎治療の種類別市場規模2014-2019 （テーブル製品、インジェクト製品、その他） ・自己免疫性肝炎治療の用途別市場規模2014-2019 （病院、クリニック、その他） ・自己免疫性肝炎治療の北米市場：主要企業・種類別/用途別市場規模 ・自己免疫性肝炎治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...Autoimmune Hepatitis is a serious condition that may worsen over time if not treated. Autoimmune Hepatitis can lead to cirrhosis and liver failure.Autoimmune hepatitis is a disease in which the body's own immune system attacks the liver and causes it to become inflamed.In 2018, the global Autoimmune Hepatitis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Autoimmune Hepatitis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Autoimmune Hepatitis...
  • 炎症性腸疾患療法の世界市場：規模・現状・予測2019-2025
    DATA909X18567 / QYResearch / 2019年11月25日 / ※当調査レポートでは、炎症性腸疾患療法の世界市場について調査・分析し、炎症性腸疾患療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（潰瘍性大腸炎、クローン病、その他）、用途別（病院、医学研究機関、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の炎症性腸疾患療法市場動向 ・主要企業別マーケットシェア ・炎症性腸疾患療法の種類別市場規模2014-2019 （潰瘍性大腸炎、クローン病、その他） ・炎症性腸疾患療法の用途別市場規模2014-2019 （病院、医学研究機関、その他） ・炎症性腸疾患療法の北米市場：主要企業・種類別/用途別市場規模 ・炎症性腸疾患療法のヨーロッパ市場：主要企業・種類別/用途別市場規模...Inflammatory bowel disease (IBD) is a chronic inflammatory bowel disease of unknown etiology, mainly including ulcerative colitis (UC) and crohn's disease (CD).The etiology may include environmental, infectious, immune and genetic factors.Because the etiology of inflammatory bowel disease is not clear, clinical symptoms are not specific, easy to be confused with other diseases, so the diagnosis is more difficult.Once misdiagnosis is caused by mistreatment, the result is mild but not cured, serious is life-threatening.The diagnosis of inflammatory bowel disease mainly includes the collection of clinical history, colonoscopy, imaging and mucosal histology.In 2018, the global Inflammatory Bowel Disease Therapy market size was...

    • ◆H&Iグローバルリサーチのお客様（例）◆